1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow ALB 109564a: new trials by email Literature Review of ALB 109564a trials Research Report on ALB 109564a
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors ALB 109564(a) (12ยด-methylthiovinblastine dihydrochloride) - Cancer | Phase 1 | Terminated | Albany Molecular Research, Inc. | 46 | 2008-09-01 | 2014-08-27 |
Neoplasms (1)
Albany Molecular Research, Inc. (1)
United States (1)
Daniel Cho, MD (1) · Eunice L. Kwak, MD, PhD (1) · Geoffrey Shapiro, MD, PhD (1) · Sridhar Mani, MD (1)